Skip to main content

MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure

07 May 2025 Evaluate
Kwality Pharmaceuticals has informed that the company has successfully concluded a regulatory audit for Zimbabwe across its General, Beta-Lactam, Cephalosporin and Oncology units, with no critical observations. This marks yet another milestone in its series of successful audits over the past year.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1761.20
Dr. Reddys Labs. 1358.00
Cipla 1382.10
Lupin 2024.40
Zydus Lifesciences 1247.15
View more..